Literature DB >> 28963794

Surrogate for oropharyngeal cancer HPV status in cancer database studies.

Uchechukwu C Megwalu1, Michelle M Chen1, Yifei Ma1, Vasu Divi1.   

Abstract

BACKGROUND: The utility of cancer databases for oropharyngeal cancer studies is limited by lack of information on human papillomavirus (HPV) status. The purpose of this study was to develop a surrogate that can be used to adjust for the effect of HPV status on survival.
METHODS: The study cohort included 6419 patients diagnosed with oropharyngeal squamous cell carcinoma between 2004 and 2012, identified in the National Cancer Database (NCDB). The HPV surrogate score was developed using a logistic regression model predicting HPV-positive status.
RESULTS: The HPV surrogate score was predictive of HPV status (area under the curve [AUC] 0.73; accuracy of 70.4%). Similar to HPV-positive tumors, HPV surrogate positive tumors were associated with improved overall survival (OS; hazard ratio [HR] 0.73; 95% confidence interval [CI] 0.59-0.91; P = .005), after adjusting for important covariates.
CONCLUSION: The HPV surrogate score is useful for adjusting for the effect of HPV status on survival in studies utilizing cancer databases.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  National Cancer Database (NCDB); cancer database; human papillomavirus (HPV); oropharyngeal cancer; surrogate marker

Mesh:

Substances:

Year:  2017        PMID: 28963794     DOI: 10.1002/hed.24921

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  2 in total

1.  Lactobacillus fermentum and Lactobacillus crispatus Do Not Have Cytotoxic Effects on HN5 Oral Squamous Cell Carcinoma Cell Line.

Authors:  Sepideh Mokhtari; Saede Atarbashi-Moghadam; Elahe Motevaseli; Soudeh Ghafouri-Fard; Ardeshir Hesampour
Journal:  Int J Dent       Date:  2021-09-28

2.  Mathematical Modeling and Computational Prediction of High-Risk Types of Human Papillomaviruses.

Authors:  Junchao Zhang; Kechao Wang
Journal:  Comput Math Methods Med       Date:  2022-07-21       Impact factor: 2.809

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.